{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:31:40Z","timestamp":1780547500320,"version":"3.54.1"},"reference-count":120,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T00:00:00Z","timestamp":1614211200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["L30MH120715"],"award-info":[{"award-number":["L30MH120715"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH15144"],"award-info":[{"award-number":["T32MH15144"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Cannabis is increasingly used by individuals with mental health diagnoses and often purported to treat anxiety and various other psychiatric symptoms. Yet support for using cannabis as a psychiatric treatment is currently limited by a lack of evidence from rigorous placebo-controlled studies. While regulatory hurdles and other barriers make clinical trials of cannabis challenging to conduct, addiction researchers have decades of experience studying cannabis use in human laboratory models. These include methods to control cannabis administration, to delineate clinical and mechanistic aspects of cannabis use, and to evaluate potential treatment applications for cannabis and its constituents. In this paper, we review these human laboratory procedures and describe how each can be applied to study cannabis use in patients with psychiatric disorders. Because anxiety disorders are among the most common psychiatric illnesses affecting American adults, and anxiety relief is also the most commonly-reported reason for medicinal cannabis use, we focus particularly on applying human laboratory models to study cannabis effects in individuals with anxiety and related disorders. Finally, we discuss how these methods can be integrated to study cannabis effects in other psychiatric conditions and guide future research in this area.<\/jats:p>","DOI":"10.3389\/fpsyt.2021.626150","type":"journal-article","created":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T07:38:24Z","timestamp":1614238704000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Human Laboratory Models of Cannabis Use: Applications for Clinical and Translational Psychiatry Research"],"prefix":"10.3389","volume":"12","author":[{"given":"Reilly R.","family":"Kayser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Haney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen Blair","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,2,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/npp.2017.198","article-title":"US epidemiology of cannabis use and associated problems","volume":"43","author":"Hasin","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"B2","unstructured":"LipariRN\n            Park-LeeE\n          Key Substance Use and Mental Health Indicators in the United States: Results from the 2018 National Survey on Drug Use and Health2019"},{"key":"B3","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1056\/nejmp1406074","article-title":"Big marijuana \u2014 Lessons from big tobacco","volume":"371","author":"Richter","year":"2014","journal-title":"N Engl J Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/dar.12459","article-title":"Legal cannabis industry adopting strategies of the tobacco industry","volume":"35","author":"Subritzky","year":"2016","journal-title":"Drug Alcohol Rev."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1007\/s11606-020-05800-7","article-title":"Medical reasons for marijuana use, forms of use, and patient perception of physician attitudes among the US population","volume":"35","author":"Azcarate","year":"2020","journal-title":"J Gen Intern Med."},{"key":"B6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1089\/can.2016.0007","article-title":"A cross-sectional survey of medical cannabis users: patterns of use and perceived efficacy","volume":"1","author":"Sexton","year":"2016","journal-title":"Cannabis Cannabinoid Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/S2215-0366(19)30401-8","article-title":"Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis","volume":"6","author":"Black","year":"2019","journal-title":"The Lancet Psychiatry."},{"key":"B8","doi-asserted-by":"publisher","first-page":"989","DOI":"10.2147\/JPR.S134330","article-title":"Cannabis as a substitute for prescription drugs \u2013 a cross-sectional study","volume":"10","author":"Corroon","year":"2017","journal-title":"J Pain Res."},{"key":"B9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1080\/10550887.2020.1811455","article-title":"The COVID-19 cannabis health study: Results from an epidemiologic assessment of adults who use cannabis for medicinal reasons in the United States","volume":"39","author":"Vidot","year":"2020","journal-title":"J Addict Dis."},{"key":"B10","volume-title":"The Health Effects of Cannabis and Cannabinoids","year":"2017"},{"key":"B11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jpsychires.2019.01.024","article-title":"Cannabis use behaviors and prevalence of anxiety and depressive symptoms in a cohort of Canadian medicinal cannabis users","volume":"111","author":"Turna","year":"2019","journal-title":"J Psychiatr Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"e2010001","DOI":"10.1001\/jamanetworkopen.2020.10001","article-title":"Association of state policies allowing medical cannabis for opioid use disorder with dispensary marketing for this indication","volume":"3","author":"Shover","year":"2020","journal-title":"JAMA Netw Open."},{"key":"B13","unstructured":""},{"key":"B14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1001\/jamapsychiatry.2020.1032","article-title":"Perspectives on cannabis research\u2014Barriers and recommendations","volume":"77","author":"Haney","year":"2020","journal-title":"JAMA Psychiatry."},{"key":"B15","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/2049463720922884","article-title":"Barriers to the wider adoption of medicinal Cannabis","volume":"14","author":"Alexander","year":"2020","journal-title":"Br J Pain"},{"key":"B16","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.copsyc.2019.04.002","article-title":"Changing landscape of cannabis: novel products, formulations, and methods of administration","volume":"30","author":"Spindle","year":"2019","journal-title":"Curr Opin Psychol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/clpt.1980.181","article-title":"Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking","volume":"28","author":"Ohlsson","year":"1980","journal-title":"Clin Pharmacol Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1007\/BF00427095","article-title":"Clinical effects and plasma levels of \u03949-Tetrahydrocannabinol (\u03949-THC) in heavy and light users of cannabis","volume":"74","author":"Lindgren","year":"1981","journal-title":"Psychopharmacology."},{"key":"B19","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1037\/a0016502","article-title":"Effectiveness of a marijuana expectancy manipulation: Piloting the balanced-placebo design for marijuana","volume":"17","author":"Metrik","year":"2009","journal-title":"Exp Clin Psychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-020-17654-y","article-title":"Placebos without deception reduce self-report and neural measures of emotional distress","volume":"11","author":"Guevarra","year":"2020","journal-title":"Nat Commun."},{"key":"B21","doi-asserted-by":"publisher","first-page":"207","DOI":"10.31887\/DCNS.2020.22.3\/blutz","article-title":"Neurobiology of cannabinoid receptor signaling","volume":"22","author":"Lutz","year":"2020","journal-title":"Dialogues Clin Neurosci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-018-22755-2","article-title":"The cannabinoid content of legal cannabis in washington state varies systematically across testing facilities and popular consumer products","volume":"8","author":"Jikomes","year":"2018","journal-title":"Sci Rep."},{"key":"B23","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1176\/appi.ajp.2015.15070907","article-title":"Prevalence and correlates of DSM-5 cannabis use disorder, 2012-2013: findings from the national epidemiologic survey on alcohol and related conditions-III","volume":"173","author":"Hasin","year":"2016","journal-title":"Am J Psychiatry."},{"key":"B24","first-page":"113","article-title":"Psychiatric comorbidity of cannabis use disorder","volume-title":"Cannabis Use Disorders","author":"Gorelick","year":"2020"},{"key":"B25","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S2215-0366(20)30074-2","article-title":"Psychiatric symptoms caused by cannabis constituents: a systematic review and meta-analysis","volume":"7","author":"Hindley","year":"2020","journal-title":"Lancet Psychiatry."},{"key":"B26","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.socscimed.2019.06.005","article-title":"Patient-reported use of medical cannabis for pain, anxiety, and depression symptoms: systematic review and meta-analysis","volume":"233","author":"Kosiba","year":"2019","journal-title":"Soc Sci Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1001\/jama.2015.6613","article-title":"Cannabinoid dose and label accuracy in edible medical cannabis products","volume":"313","author":"Vandrey","year":"2015","journal-title":"J Am Med Assoc."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e0230167","DOI":"10.1371\/journal.pone.0230167","article-title":"Mapping cannabis potency in medical and recreational programs in the United States","volume":"15","author":"Cash","year":"2020","journal-title":"PLoS ONE."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1111\/add.12634","article-title":"Just say \u201cknow\u201d: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?","volume":"109","author":"Freeman","year":"2014","journal-title":"Addiction."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/09687637.2020.1752150","article-title":"Frequent cannabis users demonstrate low knowledge of cannabinoid content and dosages","author":"Kruger","year":"2020","journal-title":"Drugs Educ Prev Policy."},{"key":"B31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.drugalcdep.2017.02.003","article-title":"Subjective and physiological effects, and expired carbon monoxide concentrations in frequent and occasional cannabis smokers following smoked vaporized, and oral cannabis administration","volume":"175","author":"Newmeyer","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"B32","doi-asserted-by":"publisher","first-page":"3353","DOI":"10.1098\/rstb.2011.0381","article-title":"Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities","volume":"367","author":"Pertwee","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B33","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s12888-019-2409-8","article-title":"Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review","volume":"20","author":"Sarris","year":"2020","journal-title":"BMC Psychiatry."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.4088\/JCP.15r10036","article-title":"Systematic review of evidence for medical marijuana in psychiatric indications","author":"Wilkinson","year":"2016","journal-title":"J Clin Psychiatry."},{"key":"B35","doi-asserted-by":"publisher","first-page":"S363","DOI":"10.1016\/s0924-977x(12)70563-1","article-title":"P.4.a.011 Post-traumatic stress disorder and medical cannabis use: a naturalistic observational study","volume":"22","author":"Reznik","year":"2012","journal-title":"Eur Neuropsychopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.psychres.2017.07.070","article-title":"Acute effects of smoked marijuana in marijuana smokers at clinical high-risk for psychosis: a preliminary study","volume":"257","author":"Vadhan","year":"2017","journal-title":"Psychiatry Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1002\/da.23032","article-title":"Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: a human laboratory study","volume":"37","author":"Kayser","year":"2020","journal-title":"Depress Anxiety."},{"key":"B38","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-319-90365-1_9","article-title":"Human laboratory models of cannabis use disorder","volume-title":"Cannabis Use Disorders.","author":"Arout","year":"2019"},{"key":"B39","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1001\/archpsyc.62.6.593","article-title":"Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry."},{"key":"B40","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1037\/a0033661","article-title":"Marijuana's dose-dependent effects in daily marijuana smokers","volume":"21","author":"Ramesh","year":"2013","journal-title":"Exp Clin Psychopharmacol."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.1038\/npp.2015.367","article-title":"Oral cannabidiol does not alter the subjective, reinforcing or cardiovascular effects of smoked cannabis","volume":"41","author":"Haney","year":"2016","journal-title":"Neuropsychopharmacology."},{"key":"B42","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamapsychiatry.2020.0927","article-title":"Association of naturalistic administration of cannabis flower and concentrates with intoxication and impairment","volume":"77","author":"Bidwell","year":"2020","journal-title":"JAMA Psychiatry."},{"key":"B43","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1007\/bf00176846","article-title":"Discriminative stimulus and subjective effects of smoked marijuana in humans","volume":"94","author":"Chait","year":"1988","journal-title":"Psychopharmacology."},{"key":"B44","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0306-4603(89)90017-8","article-title":"Some physical characteristics of NIDA marijuana cigarettes","volume":"14","author":"Chait","year":"1989","journal-title":"Addict Behav."},{"key":"B45","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/s0091-3057(97)00414-0","article-title":"Effects of expectancies on subjective responses to oral delta9-tetrahydrocannabinol","volume":"59","author":"Kirk","year":"1998","journal-title":"Pharmacol Biochem Behav."},{"key":"B46","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/S0893-133X(01)00273-1","article-title":"Effects of acute smoked marijuana on complex cognitive performance","volume":"25","author":"Hart","year":"2001","journal-title":"Neuropsychopharmacology."},{"key":"B47","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1080\/13803390600693615","article-title":"Acute effects of smoked marijuana on decision making, as assessed by a modified gambling task, in experienced marijuana users","volume":"29","author":"Vadhan","year":"2007","journal-title":"J Clin Exp Neuropsychol."},{"key":"B48","first-page":"101","article-title":"Factors influencing marijuana self-administration by humans","volume":"8","author":"Haney","year":"1997","journal-title":"Behav Pharmacol."},{"key":"B49","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s00213-005-2234-2","article-title":"Reinforcing effects of oral \u03949-THC in male marijuana smokers in a laboratory choice procedure","volume":"181","author":"Hart","year":"2005","journal-title":"Psychopharmacology."},{"key":"B50","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1369-1600.2007.00095.x","article-title":"Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor","volume":"13","author":"Cooper","year":"2008","journal-title":"Addict Biol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1037\/pha0000030","article-title":"Marijuana's acute effects on cognitive bias for affective and marijuana cues","volume":"23","author":"Metrik","year":"2015","journal-title":"Exp Clin Psychopharmacol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1037\/abn0000106","article-title":"Altered subjective reward valuation among drug-deprived heavy marijuana users: a version to uncertainty","volume":"125","author":"Hefner","year":"2016","journal-title":"J Abnorm Psychol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1037\/abn0000344","article-title":"Heavy marijuana use but not deprivation is associated with increased stressor reactivity","volume":"127","author":"Hefner","year":"2018","journal-title":"J Abnorm Psychol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1111\/adb.12621","article-title":"Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers","volume":"24","author":"Haney","year":"2019","journal-title":"Addict Biol."},{"key":"B55","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s002130050849","article-title":"Abstinence symptoms following smoked marijuana in humans","volume":"141","author":"Haney","year":"1999","journal-title":"Psychopharmacology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1038\/npp.2013.54","article-title":"Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse","volume":"38","author":"Haney","year":"2013","journal-title":"Neuropsychopharmacology."},{"key":"B57","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s00213-007-1020-8","article-title":"Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse","volume":"197","author":"Haney","year":"2008","journal-title":"Psychopharmacology."},{"key":"B58","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1007\/s00213-010-1888-6","article-title":"Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse","volume":"211","author":"Haney","year":"2010","journal-title":"Psychopharmacology."},{"key":"B59","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.biopsych.2012.07.028","article-title":"Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status","volume":"73","author":"Haney","year":"2013","journal-title":"Biol Psychiatry."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1007\/s00213-016-4298-6","article-title":"Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users","volume":"233","author":"Herrmann","year":"2016","journal-title":"Psychopharmacology."},{"key":"B61","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1373\/clinchem.2015.238287","article-title":"Controlled cannabis vaporizer administration: blood and plasma cannabinoids with and without alcohol","volume":"61","author":"Hartman","year":"2015","journal-title":"Clin Chem."},{"key":"B62","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1111\/epi.13852","article-title":"Interactions between cannabidiol and commonly used antiepileptic drugs","volume":"58","author":"Gaston","year":"2017","journal-title":"Epilepsia."},{"key":"B63","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3390\/medicines6010003","article-title":"Medicinal cannabis\u2014Potential drug interactions","volume":"6","author":"Alsherbiny","year":"2018","journal-title":"Medicines."},{"key":"B64","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/0376-8716(87)90079-2","article-title":"Effects of smoked marijuana on social interaction in small groups","volume":"20","author":"Foltin","year":"1987","journal-title":"Drug Alcohol Depend."},{"key":"B65","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3389\/fphar.2016.00309","article-title":"Current therapeutic cannabis controversies and clinical trial design issues","volume":"7","author":"Russo","year":"2016","journal-title":"Front Pharmacol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"e184841","DOI":"10.1001\/jamanetworkopen.2018.4841","article-title":"Acute effects of smoked and vaporized cannabis in healthy adults who infrequently use cannabis: a crossover trial","volume":"1","author":"Spindle","year":"2018","journal-title":"JAMA Netw Open."},{"key":"B67","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1007\/s00213-019-05369-y","article-title":"Sex differences in the acute effects of smoked cannabis: evidence from a human laboratory study of young adults","volume":"237","author":"Matheson","year":"2020","journal-title":"Psychopharmacology."},{"key":"B68","doi-asserted-by":"publisher","first-page":"172937","DOI":"10.1016\/j.pbb.2020.172937","article-title":"Acute and residual mood and cognitive performance of young adults following smoked cannabis","volume":"194","author":"Matheson","year":"2020","journal-title":"Pharmacol Biochem Behav."},{"key":"B69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2009.01.023","article-title":"Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts","volume":"103","author":"Cooper","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"B70","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/BF02245081","article-title":"The expected drug and its expected effect interact to determine placebo responses to alcohol and caffeine","volume":"115","author":"Fillmore","year":"1994","journal-title":"Psychopharmacology."},{"key":"B71","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamainternmed.2017.5308","article-title":"The achilles heel of medical cannabis research\u2014inadequate blinding of placebo-controlled trials","volume":"178","author":"Casarett","year":"2018","journal-title":"JAMA Intern Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1038\/npp.2008.120","article-title":"Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial","volume":"34","author":"Ellis","year":"2009","journal-title":"Neuropsychopharmacology."},{"key":"B73","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1007\/s11682-015-9488-z","article-title":"Cannabis and cocaine decrease cognitive impulse control and functional corticostriatal connectivity in drug users with low activity DBH genotypes","volume":"10","author":"Ramaekers","year":"2016","journal-title":"Brain Imaging Behav."},{"key":"B74","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jpsychires.2015.06.003","article-title":"Assessing measures of suicidal ideation in clinical trials with a rapid-acting antidepressant","volume":"68","author":"Ballard","year":"2015","journal-title":"J Psychiatr Res."},{"key":"B75","doi-asserted-by":"publisher","first-page":"17m11731","DOI":"10.4088\/JCP.17m11731","article-title":"Acute and longer-term outcomes using ketamine as a clinical treatment at the yale psychiatric hospital","volume":"79","author":"Wilkinson","year":"2018","journal-title":"J Clin Psychiatry."},{"key":"B76","doi-asserted-by":"publisher","first-page":"2475","DOI":"10.1038\/npp.2013.150","article-title":"Randomized controlled crossover trial of ketamine in obsessive-compulsive disorder: proof-of-concept","volume":"38","author":"Rodriguez","year":"2013","journal-title":"Neuropsychopharmacology."},{"key":"B77","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.drugalcdep.2016.07.027","article-title":"Cue-elicited increases in incentive salience for marijuana: Craving, demand, and attentional bias","volume":"167","author":"Metrik","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B78","doi-asserted-by":"publisher","first-page":"893","DOI":"10.2147\/ndt.s2627","article-title":"Attention-deficit-hyperactivity disorder and reward deficiency syndrome","volume":"4","author":"Blum","year":"2008","journal-title":"Neuropsychiatr Dis Treat."},{"key":"B79","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1038\/mp.2010.97","article-title":"Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway","volume":"16","author":"Volkow","year":"2011","journal-title":"Mol Psychiatry."},{"key":"B80","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1177\/1087054715626511","article-title":"Comorbidity of adult ADHD and its subtypes with substance use disorder in a large population-based epidemiological study","volume":"23","author":"Capusan","year":"2019","journal-title":"J Atten Disord."},{"key":"B81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s002130050422","article-title":"Benzodiazepine self-administration in humans and laboratory animals - Implications for problems of long-term use and abuse","volume":"134","author":"Griffiths","year":"1997","journal-title":"Psychopharmacology."},{"key":"B82","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.drugalcdep.2018.07.001","article-title":"Affect and cannabis use in daily life: a review and recommendations for future research","volume":"191","author":"Wycoff","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"B83","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1111\/j.1369-1600.2011.00427.x","article-title":"Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers","volume":"18","author":"Bedi","year":"2013","journal-title":"Addict Biol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"106188","DOI":"10.1016\/j.addbeh.2019.106188","article-title":"Motives matter: cannabis use motives moderate the associations between stress and negative affect","volume":"102","author":"Glodosky","year":"2020","journal-title":"Addict Behav."},{"key":"B85","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.euroneuro.2014.11.014","article-title":"Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: a randomised, double-blind, placebo-controlled study in cannabis users","volume":"25","author":"Hindocha","year":"2015","journal-title":"Eur Neuropsychopharmacol."},{"key":"B86","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1017\/S1461145709990617","article-title":"Modulation of effective connectivity during emotional processing by \u03b49-tetrahydrocannabinol and cannabidiol","volume":"13","author":"Fusar-Poli","year":"2010","journal-title":"Int J Neuropsychopharmacol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1016\/j.euroneuro.2013.06.009","article-title":"The endocannabinoid system and emotional processing: a pharmacological fMRI study with {increment}9-tetrahydrocannabinol","volume":"23","author":"Bossong","year":"2013","journal-title":"Eur Neuropsychopharmacol."},{"key":"B88","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nprot.2012.001","article-title":"Assessing fear and anxiety in humans using the threat of predictable and unpredictable aversive events (the NPU-threat test)","volume":"7","author":"Schmitz","year":"2012","journal-title":"Nat Protoc."},{"key":"B89","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.neubiorev.2020.09.024","article-title":"A way forward for anxiolytic drug development: Testing candidate anxiolytics with anxiety-potentiated startle in healthy humans","volume":"119","author":"Grillon","year":"2020","journal-title":"Neurosci Biobehav Rev."},{"key":"B90","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1016\/j.euroneuro.2015.08.001","article-title":"Dose-dependent effects of cannabis on the neural correlates of error monitoring in frequent cannabis users","volume":"25","author":"Kowal","year":"2015","journal-title":"Eur Neuropsychopharmacol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"26843","DOI":"10.1038\/srep26843","article-title":"Cannabis and tolerance: acute drug impairment as a function of cannabis use history","volume":"6","author":"Ramaekers","year":"2016","journal-title":"Sci Rep."},{"key":"B92","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1089\/acm.2018.0319","article-title":"A survey of cannabis acute effects and withdrawal symptoms: differential responses across user types and age","volume":"25","author":"Sexton","year":"2019","journal-title":"J Altern Complement Med."},{"key":"B93","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.drugalcdep.2013.12.013","article-title":"Investigation of sex-dependent effects of cannabis in daily cannabis smokers","volume":"136","author":"Cooper","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"B94","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1038\/npp.2009.200","article-title":"Individual and additive effects of the CNR1 and FAAH genes on brain response to marijuana cues","volume":"35","author":"Filbey","year":"2010","journal-title":"Neuropsychopharmacology."},{"key":"B95","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1080\/00952990.2019.1614596","article-title":"CNR1 and FAAH variation and affective states induced by marijuana smoking","volume":"45","author":"Palmer","year":"2019","journal-title":"Am J Drug Alcohol Abuse."},{"key":"B96","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.drugalcdep.2017.11.021","article-title":"Stress responding in cannabis smokers as a function of trauma exposure, sex, and relapse in the human laboratory","volume":"185","author":"Chao","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"B97","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1037\/pha0000221","article-title":"Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing","volume":"26","author":"Colizzi","year":"2018","journal-title":"Exp Clin Psychopharmacol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/npp.2017.212","article-title":"The Current state of pharmacological treatments for cannabis use disorder and withdrawal","volume":"43","author":"Brezing","year":"2018","journal-title":"Neuropsychopharmacology."},{"key":"B99","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.drugalcdep.2018.09.005","article-title":"DSM-5 cannabis withdrawal syndrome: demographic and clinical correlates in U.S. adults","volume":"195","author":"Livne","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"B100","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.drugalcdep.2016.08.622","article-title":"A contingency management method for 30-days abstinence in non-treatment seeking young adult cannabis users","volume":"167","author":"Schuster","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"B101","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1037\/0022-006X.74.2.307","article-title":"Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence","volume":"74","author":"Budney","year":"2006","journal-title":"J Consult Clin Psychol."},{"key":"B102","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1177\/1534650115590857","article-title":"Integrated cognitive behavioral therapy for comorbid cannabis use and anxiety disorders","volume":"15","author":"Buckner","year":"2016","journal-title":"Clin Case Stud."},{"key":"B103","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/BS.APHA.2017.03.004","article-title":"Cannabis pharmacology: the usual suspects and a few promising leads","volume":"80","author":"Russo","year":"2017","journal-title":"Adv Pharmacol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1098\/rstb.2011.0389","article-title":"Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders","volume":"367","author":"Campos","year":"2012","journal-title":"Philos Trans R Soc Lond B Biol Sci."},{"key":"B105","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.neuropharm.2012.06.063","article-title":"Cannabinoid facilitation of fear extinction memory recall in humans","volume":"64","author":"Rabinak","year":"2013","journal-title":"Neuropharmacology."},{"key":"B106","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.nlm.2013.09.009","article-title":"Cannabinoid modulation of prefrontal-limbic activation during fear extinction learning and recall in humans","volume":"113","author":"Rabinak","year":"2014","journal-title":"Neurobiol Learn Mem."},{"key":"B107","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/j.neuropharm.2018.10.002","article-title":"Effects of acute \u03949-tetrahydrocannabinol on next-day extinction recall is mediated by post-extinction resting-state brain dynamics","volume":"143","author":"Rabinak","year":"2018","journal-title":"Neuropharmacology."},{"key":"B108","doi-asserted-by":"publisher","first-page":"1769","DOI":"10.1038\/s41386-019-0416-6","article-title":"Influence of \u03949-tetrahydrocannabinol on long-term neural correlates of threat extinction memory retention in humans","volume":"44","author":"Hammoud","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1001\/jamapsychiatry.2018.0930","article-title":"Neuroscientifically informed formulation and treatment planning for patients with obsessive-compulsive disorder","volume":"75","author":"Dougherty","year":"2018","journal-title":"JAMA Psychiatry."},{"key":"B110","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.drugalcdep.2017.03.030","article-title":"Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress","volume":"177","author":"Childs","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"B111","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1176\/appi.ajp.2010.09091379","article-title":"Research Domain Criteria (RDoC): Toward a new classification framework for research on mental disorders","volume":"167","author":"Insel","year":"2010","journal-title":"Am J Psychiatry."},{"key":"B112","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1001\/jama.2010.555","article-title":"Rethinking mental illness","volume":"303","author":"Insel","year":"2010","journal-title":"J Am Med Assoc."},{"key":"B113","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1001\/jamapsychiatry.2014.426","article-title":"National institute of mental health clinical trials new opportunities, new expectations","volume":"71","author":"Insel","year":"2014","journal-title":"JAMA Psychiatry."},{"key":"B114","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1089\/can.2018.0049","article-title":"The endocannabinoid system: a new treatment target for obsessive compulsive disorder?","volume":"4","author":"Kayser","year":"2019","journal-title":"Cannabis Cannabinoid Res."},{"key":"B115","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/JCP.0000000000001179","article-title":"Cannabinoid augmentation of exposure-based psychotherapy for obsessive-compulsive disorder","volume":"40","author":"Kayser","year":"2020","journal-title":"J Clin Psychopharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature."},{"key":"B117","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1038\/npp.2017.305","article-title":"Enhancing endocannabinoid neurotransmission augments the efficacy of extinction training and ameliorates traumatic stress-induced behavioral alterations in rats","volume":"43","author":"Morena","year":"2018","journal-title":"Neuropsychopharmacology."},{"key":"B118","doi-asserted-by":"publisher","first-page":"168","DOI":"10.3389\/fpsyt.2014.00168","article-title":"Cannabis use and anxiety: is stress the missing piece of the puzzle?","volume":"5","author":"Temple","year":"2014","journal-title":"Front Psychiatry."},{"key":"B119","doi-asserted-by":"publisher","first-page":"46528","DOI":"10.1038\/srep46528","article-title":"Compromised external validity: federally produced cannabis does not reflect legal markets","volume":"7","author":"Vergara","year":"2017","journal-title":"Sci Rep."},{"key":"B120","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.biopsych.2016.01.004","article-title":"Changes in cannabis potency over the last two decades (1995-2014) -Analysis of current data in the United States HHS Public Access","volume":"79","author":"ElSohly","year":"2016","journal-title":"Biol Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.626150\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,25]],"date-time":"2021-02-25T07:38:32Z","timestamp":1614238712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2021.626150\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,25]]},"references-count":120,"alternative-id":["10.3389\/fpsyt.2021.626150"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2021.626150","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,25]]},"article-number":"626150"}}